It doesnt stop there, we saw compounding pharmacies also take liberties with the dosages and even formulations they offered of GLP-1s: Salt forms: The FDA had to step in and warn compounding pharmacies about using different salt forms, such as semaglutide sodium or tirzepatide acetate, instead of the actual base active ingredient found in the FDA-approved molecules
The medication targets the hypothalamus and other appetite-control centers, creating sustained satiety that makes caloric restriction feel more natural rather than forced
Although liraglutide has the same thyroid cancer concerns and it is still on the market
And if it's working and you're losing weight, then why increase
That could also mean that theyre even better at helping us burn off fata question that the researchers hope others, including the drugmakers themselves, will continue to explore
chronic pain, migraines and bone disorders to name just a few